Company / PP&E per Share
SAB Biotherapeutics, Inc. PP&E per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.43
FY2025
5-year range
$0.57 / $3.92
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.92 to $1.43 over the past 2 years.
Based on SEC 10-K filings.
1.43 in FY2025 with a 3-year CAGR of +15.2%.
Declined from $3.92 to $1.43 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 14.0% year-over-year.
- Peak pp&e per share was recorded in FY2023.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.43 | -14.0% |
| FY2024 | $1.67 | -57.5% |
| FY2023 | $3.92 | +318.3% |
| FY2022 | $0.94 | +63.8% |
| FY2021 | $0.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026